EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Dyslipidemia management in women of reproductive potential: An Expert Clinical Consensus from the National Lipid Association

Anandita Agarwala, Dave L Dixon, Eugenia Gianos, Carol F Kirkpatrick, Erin D Michos, Priyanka Satish, Kim K Birtcher, Lynne T Braun, Priyamvada Pillai, Karol Watson, Robert Wild, Laxmi S Mehta

Journal of Clinical Lipidology · 2024-09 · 18 (5) · e664-e684

DOI: 10.1016/j.jacl.2024.05.005 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Journal of Clinical Lipidology, 2024-09. Verfasst von Anandita Agarwala und 11 weiteren Autor:innen. Beteiligte Einrichtung: Center for Cardiovascular Disease Prevention Cardiovascular Division, Baylor Scott and White Health Heart Hospital Baylor Plano, Plano, TX, USA (Dr A…. Hauptthemen laut MEDLINE: Dyslipidemias. Die Arbeit wurde bisher 56-mal zitiert (Crossref) und nennt 148 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cardiovascular disease (CVD) is the leading cause of death among women and its incidence has been increasing recently, particularly among younger women. Across major professional society guidelines, dyslipidemia management remains a central tenet for atherosclerotic CVD prevention for both women and men. Despite this, women, particularly young women, who are candidates for statin therapy are less likely to be treated and less likely to achieve their recommended therapeutic objectives for low-density lipoprotein cholesterol (LDL-C) levels. Elevated LDL-C and triglycerides are the two most common dyslipidemias that should be addressed during pregnancy due to the increased risk for adverse pregnancy outcomes, such as preeclampsia, gestational diabetes mellitus, and pre-term delivery, as well as pancreatitis in the presence of severe hypertriglyceridemia. In this National Lipid Association Expert Clinical Consensus, we review the roles of nutrition, physical activity, and pharmacotherapy as strategies to address elevated levels of LDL-C and/or triglycerides among women of reproductive age. We include a special focus on points to consider during the shared decision-making discussion regarding pharmacotherapy for dyslipidemia during preconception planning, pregnancy, and lactation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

DyslipidemiasHumansFemalePregnancy

Stichwörter der Autor:innen

DyslipidemiaFamilial hypercholesterolemiaHypertriglyceridemiaLifestyle interventionsPharmacotherapyPregnancyReproductive years

Autor:innen und Institutionen

  • Center for Cardiovascular Disease Prevention Cardiovascular Division, Baylor Scott and White Health Heart Hospital Baylor Plano, Plano, TX, USA (Dr Agarwala). Electronic address: anandita.kulkarni@bswhealth.org.
  • Department of Pharmacotherapy & Outcomes Science, Virginia Commonwealth University School of Pharmacy, Richmond, Virginia, USA (Dr Dixon); Center for Pharmacy Practice Innovation, Virginia Commonwealth University, Richm…
  • Department of Cardiology, Northwell Health, New Hyde Park, Cardiovascular Institute, Lenox Hill Hospital Northwell, New York, NY, USA (Dr Gianos).
  • Midwest Biomedical Research, Addison, IL, USA (Dr Kirkpatrick); Kasiska Division of Health Sciences, Idaho State University, Pocatello, ID, USA (Dr Kirkpatrick).
  • Division of Cardiology, Department of Medicine Johns Hopkins University School of Medicine Baltimore, MD, USA (Dr Michos).
  • The University of Texas at Austin Dell School of Medicine, Ascension Texas Cardiovascular, Austin, TX, USA (Dr Satish).

Zitieren

APA

Agarwala, A., Dixon, D. L., Gianos, E., Kirkpatrick, C. F., Michos, E. D., Satish, P., Birtcher, K. K., Braun, L. T., Pillai, P., Watson, K., Wild, R., & Mehta, L. S. (2024). Dyslipidemia management in women of reproductive potential: An Expert Clinical Consensus from the National Lipid Association. Journal of Clinical Lipidology, 18(5), e664-e684. https://doi.org/10.1016/j.jacl.2024.05.005

Vancouver

Agarwala A, Dixon DL, Gianos E, Kirkpatrick CF, Michos ED, Satish P, et al. Dyslipidemia management in women of reproductive potential: An Expert Clinical Consensus from the National Lipid Association. Journal of Clinical Lipidology. 2024;18(5):e664-e684. doi:10.1016/j.jacl.2024.05.005

BibTeX
@article{Agarwala2024,
  author = {Agarwala, Anandita and Dixon, Dave L and Gianos, Eugenia and Kirkpatrick, Carol F and Michos, Erin D and Satish, Priyanka and Birtcher, Kim K and Braun, Lynne T and Pillai, Priyamvada and Watson, Karol and Wild, Robert and Mehta, Laxmi S},
  title = {Dyslipidemia management in women of reproductive potential: An Expert Clinical Consensus from the National Lipid Association},
  journal = {Journal of Clinical Lipidology},
  year = {2024},
  volume = {18},
  number = {5},
  pages = {e664--e684},
  doi = {10.1016/j.jacl.2024.05.005}
}
Kostenlos starten →